IQVIA HOLDINGS INC. Payments to Acquire Marketable Securities
IQVIA HOLDINGS INC. (IQV) reported Payments to Acquire Marketable Securities of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2024-10-31
- IQVIA HOLDINGS INC. payments to acquire marketable securities for the quarter ending 2024-09-30 was $0.00.
- IQVIA HOLDINGS INC. payments to acquire marketable securities for the quarter ending 2024-06-30 was -$1.00M.
- IQVIA HOLDINGS INC. payments to acquire marketable securities for the quarter ending 2024-03-31 was $1.00M, a 75.00% decline year-over-year.
- IQVIA HOLDINGS INC. payments to acquire marketable securities for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month |
|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$1.00M derived: sum of 2 quarters · filed 2024-10-31 | $0.00 10-Q · filed 2024-10-31 |
| 2024-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-22 | $0.00 10-Q · filed 2024-07-22 | |
| 2024-03-31 | $1.00M 10-Q · filed 2024-05-02 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $0.00 derived: sum of 2 quarters · filed 2024-10-31 | $4.00M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-22 | $4.00M 10-Q · filed 2024-07-22 | |
| 2023-03-31 | $4.00M 10-Q · filed 2024-05-02 | ||
| 2022-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $1.00M derived: sum of 2 quarters · filed 2023-11-01 | $4.00M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $3.00M 10-Q · filed 2023-08-01 | |
| 2022-03-31 | $3.00M 10-Q · filed 2023-04-28 | ||
| 2021-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $2.00M derived: sum of 2 quarters · filed 2022-10-27 | $9.00M 10-Q · filed 2022-10-27 |
| 2021-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | $8.00M 10-Q · filed 2022-07-22 | |
| 2021-03-31 | $7.00M 10-Q · filed 2022-04-28 | ||
| 2020-09-30 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | $1.00M derived: sum of 2 quarters · filed 2021-10-22 | $8.00M 10-Q · filed 2021-10-22 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $7.00M 10-Q · filed 2021-07-28 | |
| 2020-03-31 | $7.00M 10-Q · filed 2021-04-23 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22 | $0.00 derived: sum of 2 quarters · filed 2020-10-22 | $2.00M 10-Q · filed 2020-10-22 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | $2.00M 10-Q · filed 2020-07-23 | |
| 2019-03-31 | $2.00M 10-Q · filed 2020-04-30 | ||
| 2018-09-30 | $3.00M 10-Q · filed 2019-11-01 | ||
| 2018-03-31 | $1.00M 10-Q · filed 2019-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |